Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917 ·Status: COMPLETED ·Phase: PHASE3

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

NCT03876301 ·Status: COMPLETED

Clinical Trial on Treatment of Intraventricular Hemorrhage

NCT00650858 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A

NCT00989196 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors

NCT00221195 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

NCT00178607 ·Status: COMPLETED

Quality of Life Study of Helixate NexGen

NCT01053715 ·Status: COMPLETED

An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

NCT00945906 ·Status: COMPLETED ·Phase: PHASE3

Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment

NCT02396862 ·Status: COMPLETED

Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders

NCT02324517 ·Status: UNKNOWN

Improved Factor VIII Inhibitor Evaluation

NCT02726139 ·Status: WITHDRAWN

ATHN 7: Hemophilia Natural History Study

NCT03619863 ·Status: COMPLETED

Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment

NCT00623480 ·Status: COMPLETED ·Phase: PHASE3

An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B

NCT06008938 ·Status: RECRUITING

Prophylaxis Versus On-demand Therapy Through Economic Report

NCT01159587 ·Status: COMPLETED

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

NCT04398628 ·Status: RECRUITING

A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

NCT03587116 ·Status: COMPLETED ·Phase: PHASE3

Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B

NCT01228669 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A

NCT04323098 ·Status: COMPLETED ·Phase: PHASE3

A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B

NCT01708564 ·Status: COMPLETED ·Phase: PHASE1

Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301)

NCT03370913 ·Status: COMPLETED ·Phase: PHASE3

Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency

NCT00056589 ·Status: COMPLETED ·Phase: PHASE1

PF-06741086 Multiple Dose Study in Severe Hemophilia

NCT02974855 ·Status: COMPLETED ·Phase: PHASE2

Risk Models to Optimise Prophylaxis Schedules in Children With Haemophilia

NCT02585635 ·Status: COMPLETED

A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients

NCT03855696 ·Status: COMPLETED ·Phase: PHASE1